Business Context and Reporting Period
Company: Camtek Ltd.
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended December 31, 2007
Business Overview: Camtek designs, develops, manufactures, and markets automated optical inspection (AOI) systems for the printed circuit board (PCB), integrated circuit (IC) substrate, and semiconductor manufacturing and packaging industries. The company is incorporated in Israel and listed on the Nasdaq Global Market.
Key Financial Metrics
| Metric (in thousands, except per share) | 2007 | 2006 |
|---|---|---|
| Total Revenues | $70,969 | $100,055 |
| Gross Profit | $29,029 | $51,613 |
| Gross Margin | 40.9% | 51.6% |
| Operating Loss | $(7,201) | $11,932 |
| Net Loss | $(7,691) | $11,603 |
| Diluted EPS | $(0.25) | $0.39 |
| Cash and Cash Equivalents | $18,601 | $23,358 |
| Total Assets | $98,465 | $110,806 |
| Shareholders' Equity | $72,906 | $80,138 |
| Convertible Loan (Long-term) | $3,333 | $5,000 |
Operating Cash Flow: Negative $1.3 million in 2007 compared to positive $0.8 million in 2006.
Capital Expenditures: $3.2 million in 2007 (primarily facility expansion in Israel and China).
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 29% to $70.9 million, driven by a 48% drop in sales to the semiconductor manufacturing and packaging industry (Falcon systems) and a 35% decline in product sales overall. Service fees increased 49% to $11.3 million due to a growing installed base.
- Profitability Reversal: The company swung from a net income of $11.6 million in 2006 to a net loss of $7.7 million in 2007. This was primarily due to the revenue downturn and a decrease in gross margin from 51.6% to 40.9%.
- Expense Management: Selling, general, and administrative (SG&A) expenses decreased 13.4% to $24.1 million, largely due to reduced commissions and shipping costs. Research and development (R&D) costs remained relatively flat, increasing slightly to $12.1 million.
- Geographic Shift: Sales to the Asia Pacific region accounted for approximately 82% of total revenues in 2007, with China and Hong Kong representing 43% of total revenues.
Guidance, Outlook, Risks, and Contingencies
Outlook and Management Commentary: Management noted that the semiconductor industry entered a downward phase in late 2006, affecting Falcon system sales. While the PCB industry saw increased demand in the second and third quarters of 2007, the fourth quarter was weaker. The company expects the trend of increasing revenues from the Asia Pacific region to continue. No specific numerical guidance for 2008 was provided in the text.
Key Risks:
- Cyclicality: The target markets (PCB, IC substrate, semiconductor) are highly cyclical. The company faces risks of permanent demand reduction and limited ability to reduce expenses quickly due to fixed R&D and support costs.
- Competition: Intense competition exists, with dominant players like Orbotech Ltd. (PCB/IC substrate) and Rudolph Technologies Inc. (semiconductor). Competitors may offer discounts or free evaluation machines, pressuring margins.
- Intellectual Property Litigation: The company is involved in patent infringement lawsuits filed by Orbotech Ltd. (Israel) and August Technology Corporation/Rudolph Technologies (USA). While management believes liability is not probable, outcomes are uncertain.
- Supply Chain: Reliance on single-source suppliers for key components (e.g., CRG software from an insolvent supplier) poses delivery risks.
- Geopolitical: Operations are concentrated in Israel, exposing the company to regional hostilities, military mobilization, and trade restrictions.
Contingencies:
- Class Action: A purported class action complaint was filed in March 2008 alleging false and misleading statements in SEC filings between late 2005 and late 2006. Management intends to defend vigorously.
- Tax Benefits: The company benefits from Israeli "Approved Enterprise" status, providing tax exemptions. Failure to meet conditions could result in tax liabilities and refunds of prior benefits.
Investor Verification Checklist
- Market Recovery: Verify the current status of the semiconductor and PCB capital spending cycles to assess revenue recovery potential.
- Legal Proceedings: Monitor the status of the patent infringement lawsuits against Orbotech and Rudolph Technologies/August Technology for potential injunctions or damages.
- Inventory Levels: Review the $34.2 million inventory balance (including $15.85 million in completed systems) for obsolescence risks given the revenue downturn.
- Currency Exposure: Assess the impact of the New Israeli Shekel (NIS) appreciation against the USD on operating costs, as a significant portion of expenses are NIS-denominated while revenues are USD-denominated.
- Convertible Loan Covenants: Confirm continued compliance with the $5 million convertible loan covenants, specifically the requirement that shareholders' equity not fall below $45 million (currently $72.9 million) and net loss limits.